Elixir Medical Corporation To Showcase A Live Case Demonstration Of The Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System At EuroPCR
5/14/2014 7:39:50 AM
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will showcase a live case demonstration of its breakthrough DESolve® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System at EuroPCR in Paris on Tuesday, May 20th 2014. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by